Page 4 - Alyson Kuritz News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Alyson kuritz. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Alyson Kuritz Today - Breaking & Trending Today

Verismo Therapeutics Receives U.S. FDA Orphan Drug Designation for SynKIR-110™, a First-in-Class KIR-CAR T Cell Immunotherapy Candidate, for the Treatment of Mesothelioma

/PRNewswire/ Verismo Therapeutics, a clinical-stage CAR-T company and Penn spinout, and pioneer of the novel KIR-CAR platform technology, today announced. ....

University Of Pennsylvania , United States , Bryan Kim , Alyson Kuritz , Hospital Of The University Pennsylvania , Drug Administration , Verismo Therapeutics , Orphan Drug Designation , Drug Designation , Prescription Drug User Fee Act ,

New Global Survey Reveals Shift in Clinical Trial Priorities; Payment Efficiencies Emerge as Leading Concern for Sponsors, CROs and Sites

Nearly 800 clinical trial industry representatives from more than 50 countries shared top challenges and opportunities in Greenphire s market tren. ....

United States , United Kingdom , Jim Murphy , Greenphire Envisi , Alyson Kuritz ,

EpiVario Awarded NIH Grant to Advance Research in Alcohol Use Disorder (AUD)

/PRNewswire/ EpiVario, Inc., a biotech company developing novel therapeutics for memory-related psychiatric disorders, today announced it has been awarded a. ....

United States , Howard Becker , Shelley Berger , Thomas Kim , Alyson Kuritz , National Institute On Alcohol Abuse , University Of South Carolina , Prnewswire Epivario Inc , Epivario Inc , National Institute , Alcohol Abuse , Use Disorder , Philipp Mews , Medical University , South Carolina , Principal Investigator , Pharmacological Treatment , Alcohol Use , Epivario Inc ,

Verismo Therapeutics Announces Submission of IND Application to the FDA for SynKIR-110TM, a KIR-CAR T-cell Immunotherapy Candidate

/PRNewswire/ Verismo Therapeutics, a Penn-spinout and the company behind the novel KIR-CAR platform technology for CAR T-cell therapy, today announced that. ....

United States , Bryan Kim , Alyson Kuritz , Drug Administration , Mesothelin Expressing Advanced Ovarian Cancer , Investigational New Drug , Verismo Therapeutics ,

Verismo Therapeutics Announces Research Partnership with the University of Pennsylvania

/PRNewswire/ Verismo Therapeutics, a recent University of Pennsylvania spin-out company behind the novel KIR-CAR platform technology for CAR T-cells, today. ....

University Of Pennsylvania , United States , Bryan Kim , Donaldl Siegel , Michaelc Milone , Alyson Kuritz , Laboratory Medicine , Penn Perelman School Of Medicine , Research Agreement , Sponsored Research Agreement , Carl June , Perelman School , Verismo Therapeutics ,